ES2763724T3 - Preparaciones enzimáticas estables y métodos de uso de las mismas - Google Patents

Preparaciones enzimáticas estables y métodos de uso de las mismas Download PDF

Info

Publication number
ES2763724T3
ES2763724T3 ES06821673T ES06821673T ES2763724T3 ES 2763724 T3 ES2763724 T3 ES 2763724T3 ES 06821673 T ES06821673 T ES 06821673T ES 06821673 T ES06821673 T ES 06821673T ES 2763724 T3 ES2763724 T3 ES 2763724T3
Authority
ES
Spain
Prior art keywords
buffer
kit
solution
composition
range
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06821673T
Other languages
English (en)
Spanish (es)
Inventor
Amihay Freeman
Noa Hadar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ramot at Tel Aviv University Ltd
Original Assignee
Ramot at Tel Aviv University Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ramot at Tel Aviv University Ltd filed Critical Ramot at Tel Aviv University Ltd
Application granted granted Critical
Publication of ES2763724T3 publication Critical patent/ES2763724T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
ES06821673T 2005-12-27 2006-12-27 Preparaciones enzimáticas estables y métodos de uso de las mismas Active ES2763724T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75340005P 2005-12-27 2005-12-27
PCT/IL2006/001492 WO2007074454A2 (en) 2005-12-27 2006-12-27 Stable enzymatic preparations and methods of use thereof

Publications (1)

Publication Number Publication Date
ES2763724T3 true ES2763724T3 (es) 2020-05-29

Family

ID=37943776

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06821673T Active ES2763724T3 (es) 2005-12-27 2006-12-27 Preparaciones enzimáticas estables y métodos de uso de las mismas

Country Status (6)

Country Link
US (2) US8197808B2 (https=)
EP (1) EP1965763B1 (https=)
JP (1) JP5435955B2 (https=)
DK (1) DK1965763T3 (https=)
ES (1) ES2763724T3 (https=)
WO (1) WO2007074454A2 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632429B1 (en) 1999-12-17 2003-10-14 Joan M. Fallon Methods for treating pervasive development disorders
US8030002B2 (en) 2000-11-16 2011-10-04 Curemark Llc Methods for diagnosing pervasive development disorders, dysautonomia and other neurological conditions
US20080058282A1 (en) 2005-08-30 2008-03-06 Fallon Joan M Use of lactulose in the treatment of autism
US8197808B2 (en) 2005-12-27 2012-06-12 Ramot At Tel-Aviv University Ltd. Stable enzymatic preparations and methods of use thereof
JP5213137B2 (ja) * 2006-12-06 2013-06-19 コーネル リサーチ ファウンデーション， インコーポレイテッド 中程度の持続時間の神経筋遮断剤およびそのアンタゴニスト
US8658163B2 (en) 2008-03-13 2014-02-25 Curemark Llc Compositions and use thereof for treating symptoms of preeclampsia
US8084025B2 (en) 2008-04-18 2011-12-27 Curemark Llc Method for the treatment of the symptoms of drug and alcohol addiction
ES2759373T3 (es) * 2008-06-12 2020-05-08 Medtronic Xomed Inc Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
US9320780B2 (en) 2008-06-26 2016-04-26 Curemark Llc Methods and compositions for the treatment of symptoms of Williams Syndrome
EP2318035B1 (en) 2008-07-01 2019-06-12 Curemark, Llc Methods and compositions for the treatment of symptoms of neurological and mental health disorders
US10776453B2 (en) 2008-08-04 2020-09-15 Galenagen, Llc Systems and methods employing remote data gathering and monitoring for diagnosing, staging, and treatment of Parkinsons disease, movement and neurological disorders, and chronic pain
US20100092447A1 (en) 2008-10-03 2010-04-15 Fallon Joan M Methods and compositions for the treatment of symptoms of prion diseases
CA2747611C (en) 2009-01-06 2019-09-17 Curemark Llc Compositions and methods for the treatment or prevention of staphylococcus aureus infections and for the eradication or reduction of staphylococcus aureus on surfaces
WO2010080835A1 (en) 2009-01-06 2010-07-15 Curemark Llc Compositions and methods for the treatment or the prevention oral infections by e. coli
EP2226382A1 (en) 2009-03-03 2010-09-08 B.R.A.I.N. Biotechnology Research and Information Network AG Protease for wound conditioning and skin care
WO2010107488A1 (en) 2009-03-17 2010-09-23 Cornell University Reversible nondepolarizing neuromuscular blockade agents and methods for their use
US9056050B2 (en) 2009-04-13 2015-06-16 Curemark Llc Enzyme delivery systems and methods of preparation and use
CN102573794B (zh) * 2009-08-19 2017-03-15 康奈尔大学 供生理注射用的半胱氨酸
US9511125B2 (en) 2009-10-21 2016-12-06 Curemark Llc Methods and compositions for the treatment of influenza
WO2012030653A2 (en) 2010-08-29 2012-03-08 Vascode Technologies Ltd. A system and methods for multi-tasking in a clientless mobile phone
JP5976100B2 (ja) 2011-04-21 2016-08-23 キュアマーク リミテッド ライアビリティ カンパニー 神経精神障害の処置のための化合物
WO2013032745A1 (en) 2011-08-31 2013-03-07 Kci Licensing, Inc. Reduced-pressure treatment and debridement systems and methods
CN104220088A (zh) * 2012-02-02 2014-12-17 柯尔朗恩有限责任公司 酶组合物及其用于创伤愈合的用途
US10350278B2 (en) 2012-05-30 2019-07-16 Curemark, Llc Methods of treating Celiac disease
US11364286B2 (en) * 2015-10-14 2022-06-21 Newsouth Innovations Pty Limited Compositions and methods for the treatment of diseases involving mucin
RU2732224C9 (ru) * 2016-01-31 2021-06-18 Медивунд Лтд. Раноочищающая композиция для лечения ран
WO2017183018A1 (en) * 2016-04-18 2017-10-26 Mediwound Ltd Methods of debridement of chronic wounds
US12226464B2 (en) 2017-04-10 2025-02-18 Curemark, Llc Compositions for treating addiction
US11541009B2 (en) 2020-09-10 2023-01-03 Curemark, Llc Methods of prophylaxis of coronavirus infection and treatment of coronaviruses
CA3199921A1 (en) * 2020-11-25 2022-06-02 Steven M. Hernandez Scar treatment composition
CN115998690B (zh) * 2022-11-10 2024-07-26 上海泰昶生物技术有限公司 包含免疫球蛋白g降解酶的冻干制剂及其制备工艺

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB913203A (en) 1958-12-30 1962-12-19 Swift & Co Enzyme formulations for the production of tenderized meat
US3539451A (en) 1968-05-31 1970-11-10 Castle & Cooke Production of reversibly inactivated papain and ficin
US4307081A (en) 1974-01-08 1981-12-22 Gerold K. V. Klein Enzyme mixture
US4715899A (en) * 1982-10-21 1987-12-29 Subir Chanda Liquid cleaner containing inactivated protease for protein soiled contact lenses
JPH0449299A (ja) * 1990-06-14 1992-02-18 Tosoh Corp 免疫グロブリンフラグメントの精製法
DE4026591B4 (de) 1990-08-23 2005-08-25 Pleva Gmbh Vorrichtung zur Bestimmung der Beladung von Luft mit Dämpfen
JP2665639B2 (ja) * 1992-01-09 1997-10-22 テーオー食品株式会社 安定化されたチオール蛋白分解酵素を含む焼き肉のタレ
US7364565B2 (en) * 2001-07-27 2008-04-29 Ramot At Tel Aviv University Ltd. Controlled enzymatic removal and retrieval of cells
MXPA04004479A (es) * 2001-11-13 2004-08-11 Procter & Gamble Composiciones topicas que contienen enzimas estabilizadas con inhibidores.
US6692726B1 (en) * 2003-02-11 2004-02-17 Colgate Palmolive Company Enzyme containing oral composition having enhanced stability
ATE429897T1 (de) * 2003-10-10 2009-05-15 Cosmedical Aps Haarwuchshemmung
US8197808B2 (en) 2005-12-27 2012-06-12 Ramot At Tel-Aviv University Ltd. Stable enzymatic preparations and methods of use thereof

Also Published As

Publication number Publication date
JP5435955B2 (ja) 2014-03-05
US8337837B2 (en) 2012-12-25
DK1965763T3 (da) 2020-02-10
EP1965763B1 (en) 2019-11-06
JP2009521521A (ja) 2009-06-04
US8197808B2 (en) 2012-06-12
EP1965763A2 (en) 2008-09-10
US20120114631A1 (en) 2012-05-10
WO2007074454A3 (en) 2007-09-20
WO2007074454A2 (en) 2007-07-05
US20090220483A1 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
ES2763724T3 (es) Preparaciones enzimáticas estables y métodos de uso de las mismas
IL192483A (en) Distribution tool for single use
ES2675879T3 (es) Productos para el cuidado de heridas
JP2008525499A (ja) 一酸化窒素を使って傷を治療する装置及び方法
CN104519893A (zh) 用于治疗细菌感染的包含抗细菌噬菌体的混合物的组合物及其使用方法
ES2657598T3 (es) Preparación para el tratamiento de heridas y llagas que comprende hipoclorito y aminoácidos
ES2785999T3 (es) Composición para su uso en la preparación de un paciente para cirugía
ES2526640T3 (es) Composiciones para romper e inhibir la reconstitución de la biopelícula de heridas
EP4192491A2 (en) Antimicrobial matrix formed from peptide hydrogels
PT1487506E (pt) Preparação para cicatrização de feridas e prevenção da adesão da compressa à ferida
ES2795671T3 (es) Agente desbridante no enzimático y método de uso del mismo
Misra et al. Use of gauze soaked in povidone iodine for dressing acute open wounds
Burba Traumatic foot injuries in horses: surgical management
JP5796728B1 (ja) 創傷治癒を促進し生体諸臓器の被覆（コーチング）及び庇護を目的とした生体皮膜剤。
KR102096254B1 (ko) 유니티올 및 디메틸설폭사이드를 포함하는 방부제 조성물, 조성물의 용도 및 이를 사용하여 상처를 치료하는 방법
Aamer et al. Current perspectives for the use of medical ozone in veterinary medicine
RU2401116C2 (ru) Ранозаживляющий пробиотический препарат
WO2022035783A2 (en) Topical and parenteral use and administration of self-assembling amphiphilic peptide hydrogels
RU2296570C2 (ru) Способ лечения нагноившихся остаточных полостей печени после эхинококкэктомии
BR112015001019B1 (pt) Uso de um agente quelante anfotérico para prevenir alergias de contato
Atkinson et al. Irrigant selection for treating trauma wounds on injured wildlife patients
Burtoff LOCAL USE OF SULFATHIAZOLE IN MASTOIDECTOMY WOUNDS: SATISFACTORY RESULTS OBSERVED IN THIRTY PATIENTS
Some fectton of Vatbolocp
Azzam et al. Seizures: An Unusual Complication of Intrapleural Povidone–Iodine Irrigation
US20160106747A1 (en) Treating postoperative mechanical stress with an ectoine